Markus Kosch new head of Pfizer Oncology Germany

06.01.2015 15:29

Since January 1st, Professor Dr. med. Markus Kosch heads the Oncology business unit at Pfizer in Germany. In this role he is also one of the managing directors of Pfizer Pharma GmbH. He is taking over from Dr. med. Tobias Eichhorn, who takes over the management of Pfizer Oncology Austria, Switzerland, Slovenia, Croatia and Bosnia - Herzegovina and moves to Vienna.

In his new role, Markus Kosch reports to Dr. med. Andreas Penk, head of Pfizer's oncology business in the Europe, Africa and Middle East region.

Markus Kosch has many years of experience as a doctor in internal medicine and as a manager in the research-based pharmaceutical industry. He has been working internationally for Pfizer Oncology since 2010. Most recently, he was responsible for hematology and breast cancer in the Europe, Africa and Middle East region at Pfizer. Since 2006, Markus Kosch has also been an adjunct professor of internal medicine at the Medical Faculty of the Westphalian Wilhelms University of Münster.